Cytotoxic chemotherapy for advanced bladder cancer: cisplatin-containing regimens
Raghavan, D.; Pearson, B.; Watt, W.H.; Mameghan, H.; Langdon, P.; Eisinger, D.; Wines, R.
Seminars in Oncology 18(1 Suppl 3): 56-63
1991
ISSN/ISBN: 0093-7754 PMID: 2003228 Document Number: 377023
Document emailed within 1 workday
Related Documents
Abi-Aad, A.S. 1996: Chemotherapy for advanced bladder carcinoma: new molecules and regimens Acta Urologica Belgica 64(2): 43-45Niiya, F.; Ikeda, S.; Nagata, S.; Iwamoto, M.; Shirouzu, K. 2001: A case of advanced gastric cancer complicated with liver metastases responding remarkably to combined chemotherapy with 5-fluorouracil and low-dose cisplatin, with UFT and low-dose cisplatin for maintenance on an outpatient basis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(3): 391-394
Palmer, A.J.; Brandt, A. 1996: The cost-effectiveness of four cisplatin-containing chemotherapy regimens in the treatment of stages IIi B and IV non-small cell lung cancer: an Italian perspective Monaldi Archives for Chest Disease 51(4): 279-288
Nishio, S.; Kumagai, S.; Hirai, N.; Tomioka, Y.; Oota, S.; Fujiyoshi, K.; Hasuo, Y.; Sugiyama, T.; Nishida, T.; Kamura, T. 2000: Neoadjuvant chemotherapy with cisplatin and CPT-11 for advanced cervical cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(3): 429-435
Flamm, J.; Grof, F. 1986: Adjuvant topical chemotherapy with cisplatin in superficial bladder cancer Der Urologe. Ausg. a 25(1): 48-50
Dubey, S.; Brown, R.L.; Esmond, S.L.; Bowers, B.J.; Healy, J.M.; Schiller, J.H. 2005: Patient preferences in choosing chemotherapy regimens for advanced non-small cell lung cancer Journal of Supportive Oncology 3(2): 149-154
West, R.J.; Zweig, S.F. 1997: Meta-analysis of chemotherapy regimens for ovarian carcinoma: a reassessment of cisplatin, cyclophosphamide and doxorubicin versus cisplatin and cyclophosphamide European Journal of Gynaecological Oncology 18(5): 343-348
Kohira, Y.; Ishibashi, Y.; Egawa, H.; Yube, Y.; Kaji, S.; Kanda, S.; Oka, S.; Kajiyama, Y.; Sakamoto, K.; Fukunaga, T. 2019: A Case of Advanced Gastric Cancer with Pathological Complete Response after Chemotherapy(S-1/Cisplatin) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(5): 929-931
Wolf, H.; Jassem, E.; Cynowska, B.ła.; Damps, I.; Mierzejewska, E.; Słomiński, J.M. 2002: Chemotherapy of advanced non-small cell lung cancer with the combination of gemcitabine and cisplatin Pneumonologia i Alergologia Polska 70(1-2): 44-51
Kamata, T.; Hayashi, Y.; Minatoya, G.; Michiwa, Y.; Onishi, I.; Takeda, T.; Koyasaki, N.; Kanno, M. 2001: A pilot study of low-dose TS-1 and cisplatin combination chemotherapy for advanced gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(10): 1419-1422
Sakuma, F.; Kuroda, M.; Takagi, T.; Terashima, K.; Ohishi, A.; Noguchi, S.; Mizuno, A. 1999: Evaluation of chemotherapy with docetaxel and cisplatin in advanced non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(7): 927-932
Yabusaki, H.; Nashimoto, A.; Tanaka, O. 2003: Evaluation of TS-1 combined with cisplatin for neoadjuvant chemotherapy in patients with advanced gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(12): 1933-1940
Shikata, A.; Mori, K.; Watahiki, Y.; Ohara, M.; Yamazaki, M.; Hoshiya, Y.; Kosaka, A. 1997: A case of unresectable advanced cancer of the gall bladder successfully treated by arterial infusion therapy with cisplatin Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(12): 1820-1824
Rassweiler, J.; Rüther, U.; Bäuerle, K.; Bub, P.; Jipp, P.; Eisenberger, F. 1989: Polychemotherapy using the M-VEC protocol (methotrexate, vinblastine, epirubicin, cisplatin) in advanced urinary bladder cancer--effectiveness and toxicity Der Urologe. Ausg. a 28(1): 25-30
Vogl, S.E.; Berenzweig, M.; Kaplan, B.H.; Moukhtar, M.; Bulkin, W. 1979: The CHAD and HAD regimens in advanced ovarian cancer: combination chemotherapy including cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II) Cancer Treatment Reports 63(2): 311-317
Hashimoto, H.; Tokumitsu, M.; Morikawa, M.; Numata, A.; Yachiku, S.; Iuchi, H.; Yamauchi, K. 1996: Chemotherapy for advanced urothelial cancer patients with a combination of low-dose consecutive cisplatin and etoposide Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(7): 941-944
Taylor, S.G.; Murthy, A.K.; Showel, J.L.; Caldarelli, D.D.; Hutchinson, J.C.; Holinger, L.D.; Kramer, T.; Kiel, K. 1985: Improved control in advanced head and neck cancer with simultaneous radiation and cisplatin/5-FU chemotherapy Cancer Treatment Reports 69(9): 933-939
Deng, C.; Huang, R.; Lian, L. 1996: Pharmacokinetic study of intraperitoneal chemotherapy with high-dose cisplatin for advanced ovarian cancer Zhonghua Fu Chan Ke Za Zhi 31(3): 159-162
Polyzos, A.; Tsavaris, N.; Kosmas, C.; Polyzos, K.; Giannopoulos, A.; Felekouras, E.; Nikiteas, N.; Kouraklis, G.; Griniatsos, J.; Safioleas, M.; Stamatakos, M.; Pikoulis, E.; Papachristodoulou, A.; Gogas, H. 2006: Subsets of patients with advanced gastric cancer responding to second-line chemotherapy with docetaxel-cisplatin Anticancer Research 26(5b): 3749-3753
Takahashi, T.; Saikawa, Y.; Yoshida, M.; Kitagawa, Y.; Otani, Y.; Kubota, T.; Kumai, K.; Kitajima, M. 2006: A pilot study of combination chemotherapy with S-1 and low-dose cisplatin for highly advanced gastric cancer Anticancer Research 26(2b): 1631-1635